首页 | 本学科首页   官方微博 | 高级检索  
   检索      

PARP-1抑制剂3-AB对肝癌细胞增殖及凋亡的影响*
引用本文:杨书红,朱德强,占大钱,魏 双,吕 兴.PARP-1抑制剂3-AB对肝癌细胞增殖及凋亡的影响*[J].现代生物医学进展,2019,19(1):17-20.
作者姓名:杨书红  朱德强  占大钱  魏 双  吕 兴
作者单位:华中科技大学同济医学院附属同济医院妇产科;湖北省中西医结合医院普外科
基金项目:国家自然科学基金青年基金项目(81501227)
摘    要:目的:探讨PARP-1抑制剂3-AB对肝癌细胞系MHCC97-H和SMMC7721及正常肝细胞系L02的增殖与凋亡的影响。方法:细胞增殖试验观察不同浓度3-AB对三种不同细胞系细胞的增殖作用。Annexin V荧光探针标记,流式细胞学检查观察不同浓度3-AB对不同细胞系细胞凋亡的影响。结果:当3-AB浓度分别为5 mM、10 mM与20 mM时,与对照组(0 mM)相比,在培养第6天时开始出现增殖明显减慢,出现统计学差异(p0.05),第九天差异明显(p0.05)。随着浓度增加,其对肿瘤细胞系MHCC97-H和SMMC7721细胞增殖的抑制程度增加,细胞数均逐渐减少;而同样浓度梯度3-AB对人类肝细胞系L02生长则无明显的抑制作用。进一步实验发现,当3-AB浓度为5mM、10 mM与20 mM时,均可诱导肝癌细胞株MHCC97-H和SMMC7721凋亡,与对照组(0 mM)比较均有统计学差异(p0.05),且细胞凋亡率与3-AB的药物浓度相关:浓度越高,凋亡越明显。而同等浓度3-AB对肝脏细胞系L02无明显的促进凋亡作用。结论:3-AB可以抑制肝癌肿瘤细胞的增殖,促进肿瘤细胞的凋亡,对正常肝脏细胞无明显毒害作用,具有治疗肝癌的的潜在应用价值。

关 键 词:PARP-1  3-AB  肝癌细胞  增殖  凋亡
收稿时间:2018/5/20 0:00:00
修稿时间:2018/6/8 0:00:00

The Effect of PARP-1 Inhibitor 3-AB on Hepatocellular Carcinoma Cell Lines*
YANG Shu-hong,ZHU De-qiang,ZHAN Da-qian,WEI Shuang and LV Xing.The Effect of PARP-1 Inhibitor 3-AB on Hepatocellular Carcinoma Cell Lines*[J].Progress in Modern Biomedicine,2019,19(1):17-20.
Authors:YANG Shu-hong  ZHU De-qiang  ZHAN Da-qian  WEI Shuang and LV Xing
Institution:Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China,Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430031, China,Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430032, China,Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430033, China and Department of General Surgery, Hubei Provincial Hospital of Integrated Chinese & Western Medicine, Wuhan, Hubei, 430030, China
Abstract: ABSTRACT Objective: To study the effect of parp-1 inhibitor 3-AB on the proliferation and apoptosis of the hepatocellular carcinoma cell lines of MHCC97-H, SMMC7721 and hepatocellular cell line L02. Methods: Cell proliferation assay was conducted to observe the effects of 3-AB on L02, MHCC97-H and SMMC7721 cell growth. FACS was used to evaluate the apoptosis ratio of different cell lines of human liver cancer cell lines and hepatocellular cell line L02 with different 3-AB dosage. Results: 3-AB can significantly inhibit the growth rate of MHCC97-H and SMMC7721 cell lines. As the concentration increased, the suppressive effects of 3-AB were increasing. The growth inhibition was significant on the 6th and 9th day of culture. Compared with the control group(0 mM), the growth rate of MHCC97-H and SMMC7721 cell lines with different concentrations of 3-AB (5 mM, 10 mM and 20 mM)(p<0.05) were lower on the 6th day and from then on; 3-AB did not affect the growth rate of L02 cell line in the same concentration(p>0.05). Compared with the control group(0 mM), the apoptosis ratio of MHCC97-H and SMMC7721 cell lines were higher than the other 3 groups with different concentration of 3-AB (5 mM, 10 mM and 20 mM) (p<0.05). Yet it has no effect on the apoptosis of L02 cell line in the same concentration(p>0.05). Conclusion: 3-AB can inhibit the growth rate of MHCC97-H and SMMC7721 cell lines and induce the cells apoptosis. And the apoptosis ratio was variable with the different 3-AB concentrations. But different concentrations had no effect on the growth or apoptosis of L02 cell line. 3-AB can be a potential good choice for liver cancer therapy and maybe improve the patients life quality.
Keywords:PARP-1  3-AB  Hepatocellular Carcinoma Cell Line  Proliferation  Apoptosis
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号